Helge Bastian

Sigma-Aldrich Corp. operates as a life science and technology material company. It develops, manufactures, purchases and distributes a broad range of biochemical and organic chemicals. Its services include basic research, product and process development, manufacturing and production, regulatory compliance, and facility operations. was founded in May 1975 and is headquartered in St. Louis, MO.

CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany.

M2Gen Corp. provides informatics-based solutions to accelerate the discovery, development, and delivery of personalized medicine. Its solutions include Total Cancer Care Protocol and ORIEN Avatar. The company was founded by William S. Dalton in 2006 and is headquartered in Tampa, FL.

Part of Becton, Dickinson & Co., PreAnalytiX GmbH is a Swiss company that specializes in developing paxgene products for the collection, transport, storage, stabilization, and purification of nucleic acids from human specimens. The company is based in Hombrechtikon, Switzerland. The company aims to improve diagnosis, treatment, and monitoring of diseases by providing biospecimens of the highest quality.

Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA.

iXCells Biotechnologies USA LLC is a cell biology and cell technology company that provides high-quality primary cells, normal and diseased iPS cell lines, iPSC-derived cell products, custom iPSC services, and functional bioassay development and execution. iXCells Biotechnologies USA is based in San Diego, CA. The company offers cost-effective pluripotent stem cells (iPSC) differentiation services with fast turnaround time for research purposes. The company was founded in 2014 by Nianwei Lin.